Cargando…
Inhibiting translesion DNA synthesis as an approach to combat drug resistance to DNA damaging agents
Anti-cancer agents exert therapeutic effects by damaging DNA. Unfortunately, DNA polymerases can effectively replicate the formed DNA lesions to cause drug resistance and create more aggressive cancers. To understand this process at the cellular level, we developed an artificial nucleoside that visu...
Autores principales: | Choi, Jung-Suk, Kim, Seol, Motea, Edward, Berdis, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522278/ https://www.ncbi.nlm.nih.gov/pubmed/28489578 http://dx.doi.org/10.18632/oncotarget.17254 |
Ejemplares similares
-
Quantifying the energetic contributions of desolvation and π-electron density during translesion DNA synthesis
por: Motea, Edward A., et al.
Publicado: (2011) -
Combating resistance to DNA damaging agents
por: Choi, Jung-Suk, et al.
Publicado: (2018) -
A Genetic Selection for dinB Mutants Reveals an Interaction between DNA Polymerase IV and the Replicative Polymerase That Is Required for Translesion Synthesis
por: Scotland, Michelle K., et al.
Publicado: (2015) -
Development of a ‘clickable’ non-natural nucleotide to visualize the replication of non-instructional DNA lesions
por: Motea, Edward A., et al.
Publicado: (2012) -
Identification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin
por: Ziv, Omer, et al.
Publicado: (2014)